Terns Pharmaceuticals

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell TERN and other ETFs, options, and stocks.

About TERN

Terns Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company, which engages in developing a portfolio of small-molecule single-agent and combination therapy candidates for the treatment of non-alcoholic steatohepatitis, or NASH, and other chronic liver diseases. The firm's pipeline includes clinical stage development programs, including a FXR agonist, a VAP-1 inhibitor, a THR-ß agonist, and a preclinical GLP-1 receptor agonist program. 

CEO
Amy L. Burroughs
CEOAmy L. Burroughs
Employees
59
Employees59
Headquarters
Foster City, California
HeadquartersFoster City, California
Founded
2017
Founded2017
Employees
59
Employees59

TERN Key Statistics

Market cap
217.21M
Market cap217.21M
Price-Earnings ratio
-2.05
Price-Earnings ratio-2.05
Dividend yield
—
Dividend yield—
Average volume
1.64M
Average volume1.64M
High today
$2.39
High today$2.39
Low today
$2.24
Low today$2.24
Open price
$2.31
Open price$2.31
Volume
784.02K
Volume784.02K
52 Week high
$11.40
52 Week high$11.40
52 Week low
$1.87
52 Week low$1.87

Analyst ratings

71%

of 7 ratings
Buy
71.4%
Hold
28.6%
Sell
0%
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.